Nukkleus Inc. received a notice from Nasdaq stating that their prior deficiency has been cured and their securities will continue to be listed and traded on Nasdaq.
AI Assistant
NUKKLEUS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.